REHOVOT, Israel, Sept. 4, 2019 /PRNewswire/ -- Canonic, a fully owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), developing medical cannabis products, announces today that Dr. Arnon Heyman, Canonic's CEO, will present at CannX, 4th International Medical Cannabis Conference in

PETAH TIKVA, Israel, Sept. 4, 2019 /PRNewswire/ -- PolyPid Ltd., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, locally administered therapies, announced today the closing of its $50M Series E-1 preferred shares financing round. The financing was led b

TEL AVIV, Israel, Sept. 4, 2019 /PRNewswire/ -- Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy Alpha DaRT, announced today the appointment of Dr. Robert B. Den, MD, as Chief Medical Officer (CMO). In

MENLO PARK, Calif., Sept. 4, 2019 /PRNewswire/ -- Gala Therapeutics, Inc. (Gala) today announced that its RheOx™ system has received CE Mark in the European Union. In a minimally invasive procedure called Bronchial Rheoplasty™, RheOx delivers non-thermal energy to the airways to reduce mucus-producing cells

SAN CARLOS, Calif., Sept. 4, 2019 /PRNewswire/ -- Apexigen, Inc. announced today the appointment of Scott Smith to its Board of Directors. Mr. Smith joins Apexigen's Board of Directors with over 30 years of managerial and commercial experience in the biotechnology and pharmaceutical industries.

REDWOOD CITY, Calif., Sept. 4, 2019 /PRNewswire/ -- With PCOS Awareness Month upon us, Flo, the number one female health app in the U.S. and 100+ countries with more than 100 million users, today announced it has successfully developed PCOS Health Assistant, a digital self-assessment tool to help identify the risk of polycystic ovary syndrome (PCOS), a widespread women's

CRANFORD, N.J., Sept. 4, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") ("Company") (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today reported that the FDA responded to the Company's proposal to refine the endpoints in the current Phase 3 pivotal trial for Mino-Lok.The cur

BRIDGEWATER, N.J., Sept. 4, 2019 /PRNewswire/ -- Osmotica Pharmaceuticals plc ("Osmotica" or the "Company") (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced results of the Company's Extraordinary General Meeting. At the Extraordinary General Meeting of the Company held on 29 August 2019, t

SAN DIEGO, Sept. 4, 2019 /PRNewswire/ -- Viriom Inc. (San Diego, CA), has won a grant award in the city of Shaoxing, Zhejiang province, to establish its affiliate in Mainland China. Viriom opened a representative office in Beij

MANHATTAN BEACH, Calif., Sept. 4, 2019 /PRNewswire/ -- The Pancreatic Cancer Action Network (PanCAN), a leading patient advocacy organization, announced today that C